119 related articles for article (PubMed ID: 12170867)
41. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
[TBL] [Abstract][Full Text] [Related]
42. The significance of bacteriological findings at cholecystectomy.
Brismar B; Jalakas K; Malmborg AS; Strandberg A
Acta Chir Scand Suppl; 1986; 530():35-8. PubMed ID: 3460289
[TBL] [Abstract][Full Text] [Related]
43. [Antimicrobial activities of ceftriaxone against clinically isolated strains].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Jul; 45(7):774-98. PubMed ID: 1522669
[TBL] [Abstract][Full Text] [Related]
44. Combination therapy: a way to limit emergence of resistance?
Michéa-Hamzehpour M; Pechère JC; Marchou B; Auckenthaler R
Am J Med; 1986 Jun; 80(6B):138-42. PubMed ID: 3088999
[TBL] [Abstract][Full Text] [Related]
45. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
46. In-vitro activity of pefloxacin compared to other antibiotics.
Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
[TBL] [Abstract][Full Text] [Related]
47. [The histopathological and microbiological aspects in a model of acute acalculous cholecystitis: an experimental study].
Rulli F; Muzzi M; D'Antini P; Melissari M; Sianesi M; Zanella E
Acta Biomed Ateneo Parmense; 1996; 67(1-2):61-7. PubMed ID: 10021736
[TBL] [Abstract][Full Text] [Related]
48. Microbiological examinations and in-vitro testing of different antibiotics in therapeutic endoscopy of the biliary system.
Lorenz R; Herrmann M; Kassem AM; Lehn N; Neuhaus H; Classen M
Endoscopy; 1998 Oct; 30(8):708-12. PubMed ID: 9865561
[TBL] [Abstract][Full Text] [Related]
49. [Bacterial causes of meningitis in newborns].
Ignjatović M
Srp Arh Celok Lek; 2001; 129 Suppl 1():36-41. PubMed ID: 15637989
[TBL] [Abstract][Full Text] [Related]
50. [Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics].
Fazli SA; Aksebzeci T
Mikrobiyol Bul; 1989 Oct; 23(4):356-60. PubMed ID: 2488944
[TBL] [Abstract][Full Text] [Related]
51. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
[TBL] [Abstract][Full Text] [Related]
52. [Comparative in vitro susceptibility of clinical bacterial isolates to pefloxacin and 14 antibiotics].
Dolna I; Ruczkowska J; Chomontowicz M
Przegl Lek; 1992; 49(7):213-5. PubMed ID: 1297147
[TBL] [Abstract][Full Text] [Related]
53. Clinical predictors of severe gallbladder complications in acute acalculous cholecystitis.
Wang AJ; Wang TE; Lin CC; Lin SC; Shih SC
World J Gastroenterol; 2003 Dec; 9(12):2821-3. PubMed ID: 14669342
[TBL] [Abstract][Full Text] [Related]
54. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
55. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
[TBL] [Abstract][Full Text] [Related]
56. Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and haematology/oncology patients in Switzerland: a multicentre study.
Siegrist HH; Nepa MC; Jacquet A
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():51-4. PubMed ID: 10404338
[TBL] [Abstract][Full Text] [Related]
57. [Susceptibility of microorganisms to ofloxacin].
Giedrys-Kalemba S; Bilska I
Med Dosw Mikrobiol; 1993; 45(1):119-21. PubMed ID: 8231430
[TBL] [Abstract][Full Text] [Related]
58. Acute calculous cholecystitis caused by Candida lusitaniae: an unusual causative organism in a patient without underlying malignancy.
Yildirim M; Ozaydin I; Sahin I; Yasar M
Jpn J Infect Dis; 2008 Mar; 61(2):138-9. PubMed ID: 18362405
[TBL] [Abstract][Full Text] [Related]
59. [Bacteriological study of bile from the gallbladder and bile ducts of patients surgically treated for biliary pathology].
Tejero A; Riofrío P; Aiquel MJ; Brandago M; Toro X
Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):565-7. PubMed ID: 2099858
[TBL] [Abstract][Full Text] [Related]
60. [Bacteriologic findings as a prognostic factor in the course of acute cholecystitis].
Calpena Rico R; Sánchez Llinares JR; Candela Polo F; Pérez Vázquez MT; Vázquez Rojas JL; Diego Estévez M; Compañ Rosique A; Medrano Heredia J
Rev Esp Enferm Apar Dig; 1989 Nov; 76(5):465-70. PubMed ID: 2616856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
